Comparison of aripiprazole augmentation versus bupropion combination for patient with major depressive disorder

被引：1
|
作者：
Lee, K. [1 ]
Lee, J. B. [2 ]
Park, Y. W. [3 ]
Lee, J. H. [4 ]
Lee, S. J. [5 ]
Koo, B. H. [5 ]
Sung, H. M. [6 ]
Cheon, E. J. [5 ]
机构：
[1] Dongguk Univ Hosp, Psychiat, Gyeongjy, South Korea
[2] Yeungnam Univ Hosp, Psychiat, Daegu, South Korea
[3] Fatima Hosp, Psychiat, Daegu, South Korea
[4] Catholic Univ Daegu Hosp, Psychiat, Daegu, South Korea
[5] Kyungpook Univ Hosp, Psychiat, Daegu, South Korea
[6] Cha Univ Hosp, Psychiat, Gumi, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70724-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.f.003
引用
收藏
页码：S452 / S453
页数：2
相关论文
共 50 条
  • [31] Aripiprazole-Induced Gray Matter Growth in a Patient With Major Depressive Disorder With Panic Disorder
    Lai, Chien-Han
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (03) : 360 - 362
  • [32] The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder
    Ricardo Moreira
    Clinical Drug Investigation, 2011, 31 : 5 - 17
  • [33] The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder
    Moreira, Ricardo
    CLINICAL DRUG INVESTIGATION, 2011, 31 : 5 - 17
  • [34] Bupropion in the treatment of outpatients with asthma and major depressive disorder
    Brown, E. Sherwood
    Vornik, Lana A.
    Khan, David A.
    Rush, A. John
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN MEDICINE, 2007, 37 (01): : 23 - 28
  • [35] Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations
    Jefferson, JW
    Pradko, JF
    Muir, KT
    CLINICAL THERAPEUTICS, 2005, 27 (11) : 1685 - 1695
  • [36] Aripiprazole augmentation induced hypertension in depressive disorder: A case report
    Hsiao, Yi-Ling
    Chen, Shaw-Ji
    Shen, Tsu-Wang
    Chang, Chun-Hung
    Chen, Shao-Tsu
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (01): : 305 - 306
  • [37] An open pilot stud of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder
    Leuchter, Andrew F.
    Lesser, Ira M.
    Trivedi, Madhukar H.
    Rush, A. John
    Morris, David W.
    Warden, Diane
    Fava, Maurizio
    Wisniewski, Stephen R.
    Luther, James F.
    Perales, Mercedes
    Gaynes, Bradley N.
    Stewart, Jonathan W.
    JOURNAL OF PSYCHIATRIC PRACTICE, 2008, 14 (05) : 271 - 280
  • [38] The Choice of Either Quetiapine or Aripiprazole as Augmentation Treatment in a European Naturalistic Sample of Patients With Major Depressive Disorder
    Bartova, Lucie
    Fugger, Gernot
    Dold, Markus
    Kautzky, Alexander
    Swoboda, Marleen Margret Mignon
    Rujescu, Dan
    Zohar, Joseph
    Souery, Daniel
    Mendlewicz, Julien
    Montgomery, Stuart
    Fabbri, Chiara
    Serretti, Alessandro
    Kasper, Siegfried
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (02): : 118 - 127
  • [39] Antidepressant for major depressive disorder. Comparison with vortioxetine, agomelatine, desvenlafaxine and bupropion XR
    Plasencia Garcia de Diego, B. O.
    Romero Guillena, S. L.
    Navarro Pablo, R.
    Gotor Sanchez-Luengo, F.
    Santamaria Gomez, O.
    EUROPEAN PSYCHIATRY, 2018, 48 : S205 - S206
  • [40] Low and high dose aripiprazole augmentation in major depressive disorder: a randomised, open-label study
    Horikoshi, S. H.
    Miura, I. M.
    Yamamoto, S. Y.
    Abe, O. A.
    Ito, M. I.
    Watanabe, K. W.
    Nozaki, K. N.
    Kaneko, H. K.
    Yabe, H. Y.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S861 - S861
12345